Cue Biopharma Inc (CUE)
1.74
-0.17
(-8.90%)
USD |
NASDAQ |
May 23, 16:00
1.73
-0.01
(-0.57%)
After-Hours: 20:00
Cue Biopharma Profit Margin (Quarterly): -719.1% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -719.1% |
| December 31, 2023 | -737.7% |
| September 30, 2023 | -524.0% |
| June 30, 2023 | -954.1% |
| March 31, 2023 | -7.01K% |
| December 31, 2022 | -9.66K% |
| September 30, 2022 | -16.11K% |
| June 30, 2022 | -50.80K% |
| March 31, 2022 | -1.43K% |
| December 31, 2021 | -101.6% |
| September 30, 2021 | -542.5% |
| June 30, 2021 | -375.3% |
| Date | Value |
|---|---|
| March 31, 2021 | -805.2% |
| December 31, 2020 | -2.34K% |
| September 30, 2020 | -1.42K% |
| June 30, 2020 | -1.01K% |
| March 31, 2020 | -1.42K% |
| December 31, 2019 | -849.8% |
| September 30, 2019 | -710.4% |
| June 30, 2019 | -902.6% |
| March 31, 2019 | -3.05K% |
| December 31, 2018 | -3.52K% |
| September 30, 2018 | -2.80K% |
| June 30, 2018 | -4.24K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-50.80K%
Minimum
Jun 2022
-101.6%
Maximum
Dec 2021
-4.92K%
Average
-928.3%
Median
Profit Margin (Quarterly) Benchmarks
| Precision BioSciences Inc | 48.84% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.5% |
| Return on Assets | -73.66% |
| Return on Invested Capital | -97.82% |
| Operating Margin (Quarterly) | -737.8% |
| Return on Net Operating Assets | -537.7% |